Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report

75-year-old patient with cochlear implant diagnosed with very low risk prostate cancer (PSA 6.44 ng/mL, and Grade Group 1 (left apical core)) managed on Active Surveillance (AS). After four years monitoring on AS, PSA was observed to increase to 10.84 and patient was reevaluated for disease progress...

Descripción completa

Detalles Bibliográficos
Autores principales: Grossman, Tim, Morton, Kathryn A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970888/
https://www.ncbi.nlm.nih.gov/pubmed/36866336
http://dx.doi.org/10.1016/j.eucr.2023.102352
_version_ 1784897992309866496
author Grossman, Tim
Morton, Kathryn A.
author_facet Grossman, Tim
Morton, Kathryn A.
author_sort Grossman, Tim
collection PubMed
description 75-year-old patient with cochlear implant diagnosed with very low risk prostate cancer (PSA 6.44 ng/mL, and Grade Group 1 (left apical core)) managed on Active Surveillance (AS). After four years monitoring on AS, PSA was observed to increase to 10.84 and patient was reevaluated for disease progression. Due to cochlear implant, multiparametric MRI was not an imaging option and patient was referred for piflufolastat F 18-PET/CT. In addition to previously identified left sided lesion, tracer uptake was observed within the posterior transition and peripheral zone of the right lobe of the prostate, which ultimately confirmed disease progression on targeted biopsy.
format Online
Article
Text
id pubmed-9970888
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-99708882023-03-01 Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report Grossman, Tim Morton, Kathryn A. Urol Case Rep Oncology 75-year-old patient with cochlear implant diagnosed with very low risk prostate cancer (PSA 6.44 ng/mL, and Grade Group 1 (left apical core)) managed on Active Surveillance (AS). After four years monitoring on AS, PSA was observed to increase to 10.84 and patient was reevaluated for disease progression. Due to cochlear implant, multiparametric MRI was not an imaging option and patient was referred for piflufolastat F 18-PET/CT. In addition to previously identified left sided lesion, tracer uptake was observed within the posterior transition and peripheral zone of the right lobe of the prostate, which ultimately confirmed disease progression on targeted biopsy. Elsevier 2023-02-14 /pmc/articles/PMC9970888/ /pubmed/36866336 http://dx.doi.org/10.1016/j.eucr.2023.102352 Text en © 2023 The Authors https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Oncology
Grossman, Tim
Morton, Kathryn A.
Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
title Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
title_full Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
title_fullStr Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
title_full_unstemmed Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
title_short Surveillance prostate biopsy utilizing piflufolastat F 18-PET/CT targeting in the intact prostate – A case report
title_sort surveillance prostate biopsy utilizing piflufolastat f 18-pet/ct targeting in the intact prostate – a case report
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9970888/
https://www.ncbi.nlm.nih.gov/pubmed/36866336
http://dx.doi.org/10.1016/j.eucr.2023.102352
work_keys_str_mv AT grossmantim surveillanceprostatebiopsyutilizingpiflufolastatf18petcttargetingintheintactprostateacasereport
AT mortonkathryna surveillanceprostatebiopsyutilizingpiflufolastatf18petcttargetingintheintactprostateacasereport

Ejemplares similares